Phase I Trial of YHI-1501 in Healthy Adult Japanese Subjects
Phase of Trial: Phase I
Latest Information Update: 12 Jul 2017
At a glance
- Drugs NIP 022 (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions
- Sponsors Yakult Honsha
- 11 Jul 2017 Status changed from active, no longer recruiting to completed.
- 01 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 Jun 2017.
- 01 Mar 2017 Status changed from recruiting to active, no longer recruiting.